Dáil Éireann Debate, Thursday - 11 October 2018
113. Deputy Lisa Chambers asked the Minister for Health his plans to extend the age range for the HPV vaccine in view of FDA approval to extend the age in the United States of America for men and women aged 27 to 45 years of age due to supporting medical evidence it continues to be effective in preventing cervical cancer and other illnesses at upper age ranges; and if he will make a statement on the matter. [41604/18]
View answerThe immunisation programme in Ireland is based on the advice of the National Immunisation Advisory Committee (NIAC). NIAC is a committee of the Royal College of Physicians of Ireland which is comprised of experts from a number of specialties including infectious diseases, paediatrics and public health. The committee's recommendations are informed by public health advice and international best practice. All relevant and appropriate information is taken into account when deciding to make changes to the State's immunisation programmes. NIAC submits its recommendations to my Department for consideration.
No recommendation has been received by my Department in relation to extending age ranges for the HPV vaccine as outlined in the question, but my officials will bring the Deputy's query to the attention of NIAC.
